Artery medical apparatus and methods of use thereof

Information

  • Patent Grant
  • 11890017
  • Patent Number
    11,890,017
  • Date Filed
    Tuesday, August 4, 2020
    4 years ago
  • Date Issued
    Tuesday, February 6, 2024
    9 months ago
Abstract
Methods and medical apparatus for deployment within an anatomical blood vessel. The medical apparatuses comprising: a first tubular wall, a second tubular wall, within the first tubular wall, and a constricting element configured to constrict a circumference of a portion of the second tubular wall; the combination of the first tubular wall, the second tubular wall and the constricting element forms a diametrical reducer.
Description
FIELD AND BACKGROUND OF THE INVENTION

The current invention relates to a medical device to be positioned within the main pulmonary artery and/or the pulmonary artery branches, and to methods of use thereof for treating, reducing the severity of, or reducing symptoms associated with, or any combination thereof, congestive heart failure, including left ventricular failure, wherein use may in certain embodiments, affect the position and function of the interventricular septum during systole.


Congestive heart failure (CHF) means the heart does not pump out sufficient blood to meet the body's demands. CHF can result from either a reduced ability of the heart muscle to contract (systolic failure) or from a mechanical problem that limits the ability of the heart's chambers to fill with blood (diastolic failure). When weakened, the heart is unable to keep up with the demands placed upon it and the left ventricle (LV) gets backed up or congested. CHF is a progressive disease. Failure of the left side of the heart (left-heart failure/left-sided failure/left-ventricle failure) is the most common form of the disease.


CHF affects people of all ages including children, but it occurs most frequently in those over age 60, and is the leading cause of hospitalization and death in that age group. Current treatments of CHF include lifestyle changes, medications, and surgery to bypass blocked blood vessels, replace regurgitant or stenotic valves, install stents to open narrowed coronary vessels, install pump assist devices or transplantation of the heart.


Normal cardiac contraction is a finely tuned orchestrated activity dependent on muscle function, ventricular geometry and loading conditions termed preload and afterload. When CHF due to LV systolic failure occurs, it is typically associated with changes in the geometry of the ventricles, often called remodeling. The LV becomes dilated and the interventricular septum is deflected into the right ventricle (RV), resulting in decreased LV output/pumping efficiency. The efficient systolic function of the LV is dependent not only on the strength of the myocardium but also on the LV geometry, the position and shape of the interventricular septum and the geometry and function of the RV. Interventricular dependence has been documented in experimental studies which have evaluated both normal and pathological preparations in animals. LV systolic function can be directly influenced by interventions affecting the RV and the position of the interventricular septum.


Surgical pulmonary artery banding (PAB) is a technique that was described more than 60 years ago and is still in use today for children and infants with congenital heart defects, such as overflow of blood to the lungs and volume overload of the RV. PAB is typically performed through a thoracotomy and involves wrapping a band around the exterior of the main pulmonary artery (MPA) and fixing the band in place, often with the use of sutures. Once applied, the band is tightened, narrowing the diameter of the MPA, increasing resistance to flow, reducing blood flow to the lungs, and reducing downstream pulmonary artery (PA) pressure.


Surgical PAB procedures involve the risks present with all surgical procedures. In addition, use of PAB has a number of particular disadvantages and drawbacks. Primary among these drawbacks is the inability of the surgeon performing the procedure to accurately assess, from the hemodynamic standpoint, the optimal final diameter to which the PA should be adjusted. Often, the surgeon must rely upon his or her experience in adjusting the band to achieve acceptable forward flow while decreasing the blood flow sufficiently to protect the pulmonary vasculature.


It is also not uncommon for the band to migrate towards one of the main pulmonary branches (usually the left), resulting in stenosis of the other main pulmonary branch (usually the right). There have also been reports of hardening of the vessels around the band due to buildup of calcium deposits and scarring of the PA wall beneath the band, which can also inhibit blood flow. Flow resistance due to PAB may change over time, and additional surgeries to adjust band tightness occur in up to one third of patients. The band is typically removed in a subsequent operation, for example, when a congenital malformation is corrected in the child or infant.


In addition to the classical use of PAB for treatment of congenital defects in infants and children, there has been a recent report of use of surgical PAB for left ventricle dilated cardiomyopathy (LVDCM) in infants and young children. This method includes increasing the pressure load on the right ventricle by placing a band around the pulmonary artery. The increased pressure in the right ventricle caused a leftward shift of the interventricular septum and improvement of left ventricle function. It was found that the optimal degree of constriction was achieved when the RV pressure was approximately 60% to 70% of the systemic level and so that the interventricular septum slightly moved to a midline position. The success of these procedures in infants and children has been reported to be possibly due to the potential for myocyte recovery and repopulation being significantly greater for infants and young children than for adults. However, it is the position of the inventors that the geometric improvements to the failing heart due to PAB may be responsible, at least partially, for the observed improvements in LV function, and therefore PAB for adult left ventricle heart failure may demonstrate similar improvement in LV function.


The MPA is not a favorable location for positioning an implant due to its relatively large diameter (˜30 mm) and short length (˜50 mm). The full length of the MPA is not usable for an implant due to the proximity to the pulmonary valve on one end, and the bifurcation to the pulmonary branches on the other. It is estimated that the usable length of the MPA for the implant is approximately 30 mm. Implantation of a short, wide device into the MPA is very difficult, and there is significant danger that the device will rotate or otherwise not be placed concentric with the MPA, in which case near complete blockage of the MPA could occur. In addition, the device may erroneously be placed either too close to the pulmonary valve or to the bifurcation.


It would be desirable to provide a relatively simple medical apparatus which could be implanted in a minimally-invasive fashion, and which would allow an adjustment of blood flow through a vessel. Gradual reduction in the diameter of the MPA may be desirable, but is not currently feasible with the surgical PAB approaches described above. In addition, it would be desirable to use the medical apparatus for treatment of the mature adult population suffering from left ventricle (LV) failure.


The methods and apparatuses of this invention describe a medical apparatus configured to reduce a diameter of a blood vessel for treating or at least reducing the severity of a congestive failure of the heart, such as but not limited to: systolic heart failure, diastolic heart failure, left ventricle (LV) heart failure, right ventricle (RV) heart failure, congenital defects of the heart for which surgical pulmonary artery banding (PAB) is used, and any other condition which requires pulmonary artery banding (PAB).


SUMMARY OF THE INVENTION

Some embodiments of the present invention provide a medical apparatus for deployment within an anatomical blood vessel comprising:

    • a first tubular wall,
    • a second tubular wall, within the first tubular wall, and
    • a constricting element configured to constrict a circumference of a portion of the second tubular wall;
    • the combination of the first tubular wall, the second tubular wall and the constricting element forms a diametrical reducer.


In some embodiments, the first tubular wall is connected at least at one end to the second tubular wall.


In some embodiments, at least a portion of the second tubular wall is coated with a coating material.


In some embodiments, the first and second tubular walls are concentric.


In some embodiments, material of the first and second tubular walls comprises at least one of the group consisting of: Nitinol, stainless steel, Titanium, Cobalt-Chromium alloy, Tantalum alloy, polymer, Platinum alloy and any combination thereof.


In some embodiments, the first tubular wall is made of a first material and the second tubular wall is made of a second material.


In some embodiments, the first and second tubular walls are manufactured by a process selected from: laser cutting, braiding, any combination thereof.


In some embodiments, the ratio between the medical apparatus's longitudinal length (L) and diameter of the first tubular wall (Dout) is smaller than 2.


In some embodiments, the constricting element comprises a loop section.


In some embodiments, the second tubular wall comprises at least one fixation element, configured to anchor the loop section and prevent it from longitudinal movement.


In some embodiments, the constriction element further comprises a tail section configured to be pulled and/or pushed to adjust the circumference of the loop section.


In some embodiments, the circumference of the loop section is locked at the adjusted circumference


In some embodiments, the tail is configured to be detached after adjustment of the loop section circumference.


In some embodiments, the tail section is configured to extend out of the blood vessel and into a subcutaneous space.


In some embodiments, the constricting element is configured for circumference adjustment of the second tubular wall, while the medical apparatus is within the anatomic vessel.


In some embodiments, the constriction provides the second tubular wall with a radial neck section, configured for reduction of the effective diameter of the anatomical blood vessel.


In some embodiments, the medical apparatus is collapsible and configured to be delivered into the anatomic vessel via a catheter.


Some embodiments of the present invention provide a method for reduction of effective diameter of an anatomic vessel comprising:

    • providing a medical apparatus having a second tubular wall deployed within a first tubular wall;
    • deploying the medical apparatus within an anatomical blood vessel; and
    • constricting at least a portion of the second tubular wall, thereby providing the second tubular wall with a radial neck section.


In some embodiments, the step of constricting is configured for forming a diametrical reducer for the anatomical blood vessel.


In some embodiments, the step of providing further comprises providing the medical apparatus with a constricting element configured for the constricting of the portion of the second tubular wall.


In some embodiments, the constricting element comprises a loop section and a tail section.


In some embodiments, the step of constricting further comprises adjusting the constriction, before, during, and/or after the step of the deploying.


In some embodiments, the step of the deploying comprises delivering the medical apparatus into the anatomical blood vessel via a catheter.


In some embodiments, the method further comprises a step of expanding the constricted portion of the second tubular wall, while within the anatomical blood vessel.


In some embodiments, the method further comprises a step of temporarily or permanently locking the constricted section of the second tabular wall to a specific circumference.


In some embodiments, the method further comprises a step of detaching the tail section from the constricting element.


In some embodiments, the method further comprises monitoring at least one physiological parameter.





BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWING(S)

The subject matter regarded as the invention is particularly pointed out and distinctly claimed in the concluding portion of the specification. The invention, however, both as to organization and method of operation, together with objects, features, and advantages thereof, may be understood by reference to the following detailed description when read with the accompanying drawings in which:



FIG. 1 conceptually depicts the medical apparatus, according to some embodiments of the invention, having an outer tubular wall, an inner tubular wall, and a constricting element;



FIG. 2 conceptually depicts the medical apparatus, according to some embodiments of the invention, where a portion of the inner tubular wall is constricted;



FIG. 3 conceptually illustrates the medical apparatus, according to some embodiments of the invention, and its annotated dimensions;



FIGS. 4A and 4B conceptually illustrate and depict the formation of the inner tubular wall, according to some embodiments of the invention;



FIG. 5 conceptually depicts the medical apparatus, according to some embodiments of the invention, where the outer tubular wall is manufactured by laser cut process, and the inner tubular wall is manufactured by braiding process, the inner tubular wall is also demonstrated to have a coating material;



FIGS. 6A, 6B and 6C conceptually illustrate methods of use of the medical apparatus, according to some embodiments of the invention, where FIG. 6A illustrates a step of providing, FIG. 6B illustrates a step of delivering and FIG. 6C illustrates a step of adjusting of the constricting element;



FIG. 7 conceptually illustrates methods of use of the medical apparatus, according to some embodiments of the invention, optionally including a step of monitoring and/or a pulling mechanism for a step of adjusting;



FIGS. 8A and 8B conceptually illustrate methods of use of the medical apparatus, according to some embodiments of the invention, including a step of expanding of the constricted section of the inner tubular wall (FIG. 8A), and after the expansion (FIG. 8B);



FIGS. 9A, 9B and 9C conceptually illustrate methods of use of the medical apparatus, according to some embodiments of the invention, including a step of delivering (FIG. 9A) the medical apparatus into a blood vessel, as one long tubular wall and a step of forming (FIGS. 9B and 9C) the inner tubular wall, by pushing the proximal end of the outer tubular wall there-into, while the medical apparatus is deployed within the blood vessel;



FIG. 10 conceptually illustrates the medical apparatus, according to some embodiments of the invention, where both the outer and the inner tubular walls are manufactured by laser cut process;



FIG. 11 conceptually illustrates the medical apparatus, according to some embodiments of the invention, where the constricting element is deployed at the distal end of the inner tubular wall;



FIG. 12 conceptually illustrates the medical apparatus, according to some embodiments of the invention, where the medical apparatus comprises non-concentric tubular walls;



FIG. 13 conceptually illustrates the medical apparatus, according to some embodiments of the invention, where the constricting element comprises a wide band;



FIG. 14 conceptually illustrates the medical apparatus, according to some embodiments of the invention, further comprising a locking mechanism for the constricted section of the inner tubular wall;



FIGS. 15A and 15B conceptually illustrate the medical apparatus, according to some embodiments of the invention (front and side views respectively), where the constriction element further comprises at least one fixation element; and



FIG. 16 conceptually illustrates method of use steps for the medical apparatus, according to some embodiments of the invention.





It will be appreciated that for simplicity and clarity of illustration, elements shown in the figures have not necessarily been drawn to scale. For example, the dimensions of some of the elements may be exaggerated relative to other elements for clarity. Further, where considered appropriate, reference numerals may be repeated among the figures to indicate corresponding or analogous elements.


DESCRIPTION OF SPECIFIC EMBODIMENTS OF THE INVENTION

The following description is provided, alongside all chapters of the present invention, so that to enable any person skilled in the art to make use of the invention and sets forth the best modes contemplated by the inventor of carrying out this invention. Various modifications, however, will remain apparent to those skilled in the art, since the generic principles of the present invention have been defined specifically to provide a medical apparatus configured to reduce a diameter of a blood vessel for treating or at least reducing the severity of a congestive failure of the heart, such as but not limited to: systolic heart failure, diastolic heart failure, left ventricle (LV) heart failure, right ventricle (RV) heart failure, congenital defects of the heart for which surgical pulmonary artery banding (PAB) is used, and any other condition which requires pulmonary artery banding (PAB).


As used herein, in one embodiment, the term “about”, refers to a deviance of between 0.0001-5% from the indicated number or range of numbers. In one embodiment, the term “about”, refers to a deviance of between 1-10% from the indicated number or range of numbers. In one embodiment, the term “about”, refers to a deviance of up to 25% from the indicated number or range of numbers.


According to some embodiments, the term “a” or “one” or “an” refers to at least one.


According to some embodiments the present invention provides a stent-like medical apparatus, as demonstrated at least in FIG. 1, which is configured to reduce the effective diameter of an anatomical blood vessel (150).


According to some embodiments, the medical apparatus (100) comprising:

    • an outer tubular wall (110),
    • an inner tubular wall (120) within the outer tubular wall, and
    • a constricting element (130) configured to tighten at least a portion (121) of the inner tubular wall (120).


According to some embodiments, the combination of the outer tubular wall (110), the inner tubular wall (120) and the constricting element (130) forms a diametrical reducer, which is suitable to be implanted within an anatomical blood vessel (150).


According to some embodiments, the constriction (121) provides the inner tubular wall (120) with a radial neck section (125). According to some embodiments, the neck section (125) is configured for reduction of the effective diameter of an anatomical blood vessel (150). According to some embodiments a gradual adjustment of the constricting element (130) can cause a gradual reduction of the effective diameter of the anatomical blood vessel.


According to some embodiments, the inner and outer tubular walls (110,120) are connected at their proximal ends (as demonstrated at least in FIGS. 3, 10 and 11), at their distal ends (as demonstrated in FIGS. 5 and 12) or at both ends (not shown). According to a preferred embodiment, the inner and outer tubular walls (110,120) are connected at their proximal ends, configured for more stable blood flow within the medical apparatus (100).


According to some embodiments, in the case where the inner and outer tubular walls are connect at only one end (distal or proximal), the constriction or an adjustment of the constriction can cause a change in the overall longitudinal length (Lin) of the inner tubular wall (120).


According to some embodiments, the medical apparatus further comprises an arched section (140), for a non-limiting example a torus-like portion (as demonstrated at least in FIG. 2), configured to connect between the proximal ends and/or the distal ends of the inner and outer tubular walls (110,120).


According to some embodiments, the outer and inner tubular walls (110,120) are concentric. According to some embodiments, the medical apparatus is axisymmetric.


According to some embodiments, the material of the outer and inner tubular walls comprises at least one from the group consisting of: Nitinol, stainless steel, Titanium, Cobalt-Chromium alloy, Tantalum alloy, polymer, Platinum alloy and any combination thereof.


According to some embodiments, the outer tubular wall is made of a first material and the inner tubular wall is made of a second material. According to some embodiments, the outer and inner tubular walls are made of the same material.


According to some embodiments, at least a part of the inner tubular wall is coated (128), as demonstrated in FIG. 5 in order to cause the blood flow in the blood vessel (150) to primarily flow through the inner tubular wall (120). The coating material can be selected, for a non-limiting example, from: silicone elastomers, urethane containing polymers (such as polyurethane, silicone-polyurethane, polycarbonate urethanes, and silicone polycarbonate urethanes), PTFE, PLA (including PLGA, PLLA), xenograft or allograft tissue (such as pericardial tissue).


According to some embodiments, at least one of the outer and inner tubular walls (110,120) is made of a collapsible memory shape material, therefore self-expanding material. According to some embodiments, at least one of the outer and inner tubular walls (110,120) is manufactured by laser cut process. According to some embodiments, at least one of the outer and inner tubular walls (110,120) is manufactured by braiding. According to a preferred embodiment the outer tubular wall (110) is manufactured by a laser cut process and the inner tubular wall (120) is manufactured by braiding (as shown in FIG. 5).


According to some embodiments, the ratio between the medical apparatus's (100) longitudinal length (L) and the diameter of the outer tubular wall (Dout) is smaller than a predetermined numeral (N=L/Dout) selected from the group consisting of: 3, 2.5, 2, 1.5, 1, 0.5, 0.3 and any ratio within this range. According to a preferred embodiment, N is smaller than 1.5. The dimension annotations for the medical apparatus can be found in FIG. 3.



FIG. 3 demonstrates an example where the overall length of the apparatus L is determined by the length of the outer tubular wall (L=Lout); alternately, FIG. 7 demonstrates an example where the overall length of the apparatus L is determined by the length of the inner tubular wall (L=Lin). FIG. 7 also demonstrates embodiments where the inner tubular wall extends out of the outer tubular wall (Lin>Lout) and where at least a part of the protruding section (123) of the inner tubular wall (120) is in contact with the anatomical blood vessel (150).


According to some embodiments, the constricting element (130) comprises a loop section (131), which can comprise one of: a ring, a band, a hoop, a noose, a hitch and any combination thereof.


According to some embodiments, the circumference of the loop section (131) is predetermined and fixed before delivery into the anatomical blood vessel. According to some embodiments, the circumference of the loop section (131) can be adjusted. The circumference adjustment can be conducted prior to the insertion of the medical apparatus (100) into the anatomical blood vessel (150). For a non-limiting example, a physician's (or a care giver) prior to insertion adjustment is according to the patient's clinical condition. Alternatively, the circumference adjustment can be conducted while the medical apparatus is within the blood vessel (150), e.g. during the implantation procedure and/or any time after implantation. According to some embodiments the adjustment can be gradual, i.e., over hours, days or weeks after implantation. According to some embodiments, the adjustable loop section (131) can be only tightened, and according to some embodiments it can be expandable as well, for a non-limiting example the adjustable loop section (131) can be expanded by an inflatable balloon (330), as demonstrated in FIG. 8A, and after expansion in FIG. 8B.


According to some embodiments, the loop section (131) can be positioned at any location along the longitudinal axis X of the inner tubular wall (120). According to some embodiments, the loop section (131) is deployed at a predetermined location, prior to insertion of the medical apparatus to the blood vessel (150), as demonstrated in FIGS. 6A and 11. FIG. 11 demonstrates fixation of the loop section (131) at the distal end of the inner tubular wall (120), where the medical apparatus (100) is shown after its implantation within the anatomical blood vessel.


According to some embodiments, the loop section (131) is fixated at a particular location along the longitudinal axis X by at least partially weaving the loop section (131) through the struts of the outer tubular wall (110), as demonstrated in FIGS. 9C and 12, thereby securing the loop section (131) in place.


According to some embodiments, the medical apparatus (100) is collapsible and self-expanding and is configured to be delivered into an anatomical blood vessel (150) via a delivering system, e.g. a catheter (310), as demonstrated in FIG. 6B. In this example, the catheter's tip is marked by a large arrow (311) pointing to the direction of its' insertion; the withdrawal direction of the catheter's outer sheath (312), which releases the medical apparatus (100) into the anatomical blood vessel (150), is marked by small arrows (313). According to some embodiments, the medical apparatus (100) can be provided to the physician (or a care giver) together with the delivering catheter (310), where the medical apparatus (100) is already crimped there within, as shown in FIG. 6B.


According to some embodiments, the constricting element (130) further comprises a tail section (132) configured to be pulled (or pushed, if the tail section is non-flexible), in some embodiments, by a mechanism in the handle of the delivery system and thereby adjust the circumference of the loop section (131) and accordingly the neck section (125) of the inner tubular wall.


According to some embodiments, the constricting element comprises an adjusting mechanism (320). In one embodiment, the adjusting mechanism (320) comprises a folded wire, where the folded section is passed through a tube element (321) and forms the loop section (136), which extends out the distal end of the tube element (321), and where two tail section/s (132) extend out of the proximal end of the tube element (321). In another embodiment the adjusting mechanism (320) comprises a looped wire with a sliding knot (hence the loop section), with the single wire passed through a tube element (321) and extending out of its distal end, and where the wire's single tail (hence tail section), extends out of the tube element's (321) proximal end. According to both adjusting mechanism (320) examples, by pulling the wire's tail section/s (132), while holding the tube element (321) stationary, the wire's loop section (136) is tightened and thereby its circumference is reduced.


According to some embodiment, the proximal end of the adjusting mechanism (320) can be extended out of the blood vessel and into a subcutaneous space, which can provide access for post procedure adjustment (e.g. post implantation adjustment). More specifically, the wire's tail section/s (132) together with the proximal end of the tube element (321) can be extended out of the blood vessel and into a subcutaneous space.


According to some embodiments, the tail section (132) extends out of the blood vessel, for a non-limiting example, through the right side of the heart and to a subcutaneous space. According to some embodiments, an actuator (350) can further pull and/or push the proximal end of the tail section (132) for adjustment of the circumference of the loop section (131) of the constricting element (130), as demonstrated in FIG. 7.


According to some embodiments, the loop section (131), after its circumference adjustment, can be temporarily or permanently fixed or locked to the selected circumference, and according to some embodiments, the tail section (132) can be detached (133) from the loop section (131), for a non-limiting example, at a point near the medical apparatus, as demonstrated in FIG. 6C.


According to some embodiments, the medical apparatus (100) is delivered as a single tubular wall (115) where the inner tubular (120) wall is formed by radially folding at least one end (distal and/or proximal end) of the single tubular wall (115) there-into and into the loop section (130), and thereby to form the inner tubular wall (120) with a diameter Din<Dout. According to some embodiments, the folding and forming of the inner tubular wall (120) can be conducted at a prior stage, e.g. at the manufacturing stage, as demonstrated in FIGS. 4A and 4B, or while within the anatomical blood vessel (150), as demonstrated in FIGS. 9A-9C.


According to some embodiments the present invention provides a method (200) for reducing the effective diameter of an anatomic vessel (150). The method (200) comprising steps of:

    • providing (210) a medical apparatus (100) having an inner tubular wall (120) within an outer tubular wall (110);
    • deploying (220) the medical apparatus within an anatomical blood vessel; and
    • constricting (230) at least a portion (121) of the inner tubular wall (120), thereby providing the inner tubular wall (120) with a radial neck section (125).


According to some embodiments, the step of constricting (230) is configured for forming a diametrical reducer for the anatomical blood vessel (150). According to some embodiments, the constricting is gradual, by means of step wise constriction over a predetermined period of time, for a non-limiting example, every couple of days or weeks; which can lead to a gradual and controlled reduction of the effective diameter of the anatomical blood vessel.


According to some embodiments, the step of providing (210) further comprises providing (211) the medical apparatus with a constricting element (130) configured for the constricting of the portion (121) of the inner tubular wall (120). According to some embodiments, the constricting element (130) comprises a loop section (131) and can further comprise a tail section (132), as detailed above.


According to some embodiments, the step of constricting (230) further comprises adjusting (231) the constriction. Adjusting the constriction can be at any time of the treatment procedure, i.e. before deployment of the medical apparatus (as in FIG. 6A), during the deployment (while at least part of the delivery system is in the anatomical vessel), and after the step of the deploying (220); according to the latter (after the deployment), the step of adjusting (231) is conducted while the medical apparatus is within the anatomical vessel (150), as demonstrated in FIGS. 6C, 7 and 10.


According to some embodiments, the adjusting can be gradual, for gradual and controlled adjustment of the effective diameter of the anatomical blood vessel.


According to some embodiments, the step of deploying (220) comprises delivering (221) the medical apparatus by a trans-catheter procedure into the anatomical blood vessel (150) via a catheter (310), as demonstrated in FIGS. 6B and 9A.


According to some embodiments, the method (200) further comprises a step of expanding (240) the constricted portion of the inner tubular wall, while within the anatomical blood vessel (150), for a non-limiting example: by an inflatable balloon (330), delivered and controlled by a catheter (331), as demonstrated in FIG. 8A, or according to another non-limiting example by the adjusting mechanism (320), as described in FIGS. 6C and 12, in the case where the wire is non-flexible. According to some embodiments, the expanding takes place either at the end of the treatment, in which the constriction is expanded to terminate the therapy, or during the deployment process, where the expanding may be required in the case where the medical apparatus has been constricted too tightly, and needs to be expanded and retightened again. According to some embodiments the expanding can be gradual.


According to some embodiments, the method (200) further comprises a step of temporarily or permanently locking (250) the constricted section of the inner tabular wall (120) to a specific circumference. According to some embodiments, the locking can be performed by using a locking mechanism (372) for the constricted area of the inner tubular wall (120), for a non-limiting example as demonstrated in FIG. 14.


According to some embodiments, the method (200) further comprises a step of detaching (260) the tail section (132) of the constricting element (130), according to some embodiments after the step of locking (250), as demonstrated in FIG. 6C (133). The tail section (132) can then be retracted out of the anatomical blood vessel and patient's body together with the delivery system.


According to some embodiments, in the case where the medical apparatus (100) is delivered as a single tubular wall (115), the providing (210) comprises forming (212) the inner tubular wall (120) by pushing in at least one end-portion (111) of the single tubular wall (115) and radially folding thereof into. According to some embodiments, the step of forming (212) can be performed before the step of deploying (220) the medical apparatus; according to other embodiments the step of forming (212) can be performed after the step of deploying (220), while the medical apparatus (100) is within the anatomical blood vessel (150), by using a catheter (360). According to a preferred embodiment, the forming (212), before or while the medical apparatus is within the blood vessel, can be achieved when at least part of the single tubular wall (115) is manufactured by a braiding process.


According to some embodiments, the method (200) further comprises monitoring (270) at least one physiological parameter, in order examine the effects of treatment by use of the medical apparatus. According to some embodiments, the monitoring (270) is performed during at least one of the steps of: deploying (220), delivering (221), forming (212), constricting (230), adjusting (231), expanding (240), locking (250) and detaching (260). According to a preferred embodiment, the monitoring (270) is configured for the adjusting (231) of the constriction of the inner tubular wall (120). According to some embodiments, the at least one monitored physiological parameter can be compared to a baseline reading of the same (e.g. prior to treatment), in order examine the effects of treatment.


According to some embodiments, monitoring (270), comprises at least one of:

    • measuring blood pressure; for non-limiting examples: measuring the right ventricle (RV) systolic pressure, measuring the left ventricle (LV) systolic pressure; measuring the RV diastolic pressure; measuring the LV diastolic pressure; measuring the pressure gradient across the vessel constriction;
    • imaging the constricted anatomical blood vessel and/or it's adjacent blood vessel/s, and measuring degree of the vessel/s's constriction; and
    • measuring heart rate;
    • any combination thereof.


According to some embodiments, a therapeutic result for the use of the medical apparatus (100) can be at least one of the group consisting of:

    • an increase in the left ventricle ejection fraction (LVEF);
    • a decrease in the left ventricle end diastolic pressure (LVEDP);
    • improvement in the clinical symptoms of heart failure; and
    • any combination thereof.


Reference is now made to FIGS. 1 and 2 (side views), which conceptually depict the medical apparatus (100), according to some embodiments of the invention, having an outer tubular wall (110), an inner tubular wall (120), and a constricting element (130) comprised of a loop section (131) and a tail section (132). The constricting element (130) is configured to constrict a circumference (121) of a portion of the inner tubular wall (120) and provide the inner tubular wall with a radial neck section (125), as shown in FIGS. 1 and 2, before and after constriction (respectively).


Reference is now made to FIG. 3 (side cross-sectional view), which conceptually illustrates the medical apparatus, according to some embodiments of the invention, and its annotated dimensions. FIG. 3 shows: the medical apparatus's longitudinal axis X, radial axis r and angular axis θ, according to a cylindrical coordinate system; the outer diameter of the medical apparatus (100), which is actually the diameter of the outer tubular wall Dout, the diameter at the narrowest section of the inner tubular wall Dneck; the longitudinal length of the inner tubular wall Lin; and the total length of the medical apparatus L, which in this case is the length of the outer tubular wall.


Reference is now made to FIGS. 4A and 4B (side cross-sectional view and front view, respectively), which conceptually illustrate and depict the formation of the inner tubular wall, according to some embodiments of the invention. According to some embodiments, the medical apparatus (100) is manufactured as a single tubular wall (115). The inner tubular (120) wall is formed by radially folding at least one end (distal and/or proximal) of the single tubular wall (115) there-into and according to some embodiments also into the loop section, and thereby forming the inner tubular wall (120) with a diameter Din<Dout.



FIGS. 4A and 4B demonstrate the folding and forming of the inner tubular wall (120) conducted at a prior stage, e.g. at the manufacturing stage. FIG. 4A demonstrates a longitudinal view at the beginning of the folding process, while FIG. 4B depicts a frontal view, demonstrating the folded arched section (140). FIGS. 9A-9C demonstrate the folding and forming of the inner tubular wall (120) conducted while the medical apparatus is within the anatomical blood vessel (150).


According to a preferred embodiment, the forming, before or while the medical apparatus is within the blood vessel, can be achieved when at least part of the single tubular wall (115) is manufactured by a braiding process.


Reference is now made to FIG. 5 (side view), which conceptually depicts the medical apparatus (100), according to some embodiments of the invention, where the outer tubular wall (110) is manufactured by laser cut process (119), and the inner tubular wall (120) is manufactured by braiding process (129). FIG. 5 further demonstrates the inner tubular wall (120) coated with a coating material (128) configured to cause the blood flowing through the blood vessel to primarily flow through the constricted section of the inner tubular wall. FIG. 5 further demonstrates that the inner and outer tubular walls (110,120) are connected at their distal end (127) by suture connection or by any other means known in the art.


Reference is now made to FIGS. 6A, 6B and 6C (side cross section views), which conceptually illustrate methods of use of the medical apparatus, according to some embodiments of the invention. FIG. 6A illustrates a step of providing of the medical apparatus, where the circumference of the constricting element (130) is set or adjusted at a prior stage, e.g. at the time of manufacture and/or before the deployment of the medical apparatus (100) within the blood vessel.



FIG. 6B illustrates a step of delivering into the blood vessel, where the medical apparatus is in a collapsed configuration, being delivered be a catheter (310). The catheter's tip is marked by a large arrow (311) which points to the direction of its' insertion, and the small arrows point to the withdrawal direction of the catheter's sheath (312), which releases the medical apparatus (100) into the anatomical blood vessel (150).



FIG. 6C illustrates a step of adjusting of the constricting element (130). According to some embodiments the at least a portion (121) of the inner tubular wall (120) is tightened and adjusted by an adjusting mechanism (320). According to some embodiments the adjusting mechanism (320) comprises a folded wire which is at least partially passed through a tube element (321). The wire is therefore configured to have the loop section (136) which extends out the distal end of tube element (321) and two tail wires, as the tail section (132), which extend out of the proximal end of the tube element (321). According to some embodiments, the adjusting mechanism (320) comprises a looped wire with a sliding knot with the single wire passed through a tube element (321). The wire is therefore configured to have the loop section (136) which extends out the distal end of tube element (321) and the tail section (132) which extends out of the proximal end of the tube element (321).


A counter-force holding the tube element (321) stationary, while the wire tail/s (132) is/are pulled or pushed, can tighten or expand the circumference of the wire loop section (136), respectively.


According to some embodiments, the tube element and the wire tail section extend out of the blood vessels and to a subcutaneous space for access for later adjustment. According to other embodiments the tube and the wire tail are connected to, and operated by, the delivery system.



FIG. 6C further demonstrates the optional step of detaching (260) at least a part of the tail section from the constricting element (133); the tail section (132) can then be retracted out of the anatomical blood vessel and out of the patient's body.


Reference is now made to FIG. 7 (side cross section view), which conceptually illustrates methods of use of the medical apparatus, according to some embodiments of the invention. FIG. 7 demonstrates the step of monitoring (260), as mentioned above, optionally using a monitoring device (340) for displaying the monitoring features. FIG. 7 further demonstrates an actuator or a pulling mechanism (350) connected to the tail section (132) of the constricting element (130), configured for the step of adjusting (231), where the tail section (132) is pulled by a mechanism in the handle (not shown) of the delivery system, or where the tail section extends out of the blood vessel and to a position in the subcutaneous space, where it can be later used to adjust the level of constriction.


Reference is now made to FIGS. 8A and 8B (side cross section views), which conceptually illustrate methods use of the medical apparatus, according to some embodiments of the invention. FIG. 8A demonstrates the step of expanding (240) of the constricted section together with the loop section (131), using an inflatable balloon (330) being delivered and controlled be a catheter (331). FIG. 8B demonstrates the constricted section after the expansion. As mentioned above, the steps of adjusting, expanding and detaching can be monitored and displayed by the monitoring device (340).


Reference is now made to FIGS. 9A, 9B and 9C (side cross section views), which conceptually illustrate the formation of the inner tubular wall (120), while the medical apparatus is within the anatomical blood vessel (150), according to some embodiments of the invention. FIG. 9A demonstrates the step of delivering the medical apparatus into a blood vessel (150), as a collapsed long single tubular wall (115), delivered by catheter (310).



FIGS. 9B and 9C demonstrate the step of forming (212) the inner tubular wall (120), by pushing the proximal end (111) of the long tubular wall (115) and radially folding it there-into. According to a non-limiting example of FIG. 9B, the loop section (131) can be pre-positioned within the single tubular wall (115) close to the inner circumference of what will later be the outer tubular wall (but not attached to it), and after the folding step, the loop section (131) is positioned between the outer (110) and the inner (120) tubular walls.


According to a non-limiting example of FIG. 9C, the loop section (131) can be initially attached (for example braided) to the single tubular wall (115) along the outer circumference of what will later be the inner tubular wall, and then be radially folded together with the proximal end (111); therefore after the folding step, the loop section (131) remains along the outer circumference of the newly formed inner tubular wall (120).


The forming is conducted by the delivery system (310) having a tubular pushing tube (360).


Reference is now made to FIG. 10 (side cross section view), which conceptually illustrates the medical apparatus, according to some embodiments of the invention, where both the outer (110) and the inner (120) tubular walls are manufactured by laser cut process, and therefore both are configured with a firm construction.


Reference is now made to FIG. 11 (side cross section view), which conceptually illustrates the medical apparatus, according to some embodiments of the invention, where the constricting element (130) is positioned at the distal end of the inner tubular wall, and thereby providing the medical apparatus with a nozzle configuration.


Reference is now made to FIG. 12 (side cross section view), which conceptually illustrates the medical apparatus, according to some embodiments of the invention, where the medical apparatus (100) comprises non-concentric tubular walls (110,122). FIG. 12 describes a non-limiting example where the loop section (131) is connected or anchored to the inner surface of the outer tubular wall (110) at least at one circumferential location (117) which anchors the loop section (131) and prevents it from moving in a longitudinal direction, or dislodging from the medical apparatus. According to the presented example of FIG. 12, the anchored loop section (131) is further prevented from radial migration of the connection location (117), and therefore the constricted inner tubular wall (120) is pulled towards the anchoring location (117). By pulling on the tail section (132), the loop section (131) tightens the inner tubular wall (122) into a constricted diameter that is not concentric with the outer tubular wall (110). FIG. 12 further demonstrates the configuration of the constricting element configured as the adjusting mechanism (320) having a wire and a tube element.


Reference is now made to FIG. 13 (side cross section view), which conceptually illustrates the medical apparatus, according to some embodiments of the invention, where the constricting element comprises a wide band (371), configured for a longer section of constricted diameter, which in some embodiments provides a more stable flow pattern and/or a more pronounce pressure differential across the medical apparatus during blood flow.


Reference is now made to FIG. 14 (side cross section view), which conceptually illustrates the medical apparatus, according to some embodiments of the invention, further comprising a locking mechanism (372) for the constricted section of the inner tubular wall (120). According to some embodiment, the locking mechanism (372) comprises a band with ratchet pins (373) and a screw connection (374), such that the band can be can be tightened by tightening the screw connection, and remain fixed at the set tightened position. According to some embodiments the screw is operated by a mechanism in the delivery system.


Reference is now made to FIGS. 15A and 15B (side cross section view and front cross section view, respectively), which conceptually illustrate the medical apparatus, according to some embodiments of the invention, where the constriction element (130) further comprises at least one fixation element (135), which in this example is located on the exterior circumference of the inner tubular wall. The at least one fixation element (135) is configured to specifically position the loop section (131) of the constriction element and prevent it from longitudinal movement, while allowing its degree of constriction to be adjusted. According so some embodiments, the fixation element/s (135) comprise at least one of: a ring, a band, a suture, a hook, a hoop, a noose, a hitch and any combination thereof.


Reference is now made to FIG. 16, which conceptually illustrates optional method of use steps for the medical apparatus, according to some embodiments of the invention. FIG. 16 shows the method steps in a map-like configuration, to conceptually demonstrate the optional method paths.


While certain features of the invention have been illustrated and described herein, many modifications, substitutions, changes, and equivalents will now occur to those of ordinary skill in the art. It is, therefore, to be understood that the appended claims are intended to cover all such modifications and changes as fall within the true spirit of the invention.


All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention. To the extent that section headings are used, they should not be construed as necessarily limiting. In addition, any priority document(s) of this application is/are hereby incorporated herein by reference in its/their entirety.

Claims
  • 1. A method for treating an adult patient, the method comprising: selecting an adult patient with a therapeutic goal of decreasing left ventricle end diastolic pressure;implanting a medical device in a pulmonary artery of the patient;reducing an effective diameter of a portion of the pulmonary artery with the medical device by adjusting an inner diameter of the medical device; andaffecting the decrease in left ventricle end diastolic pressure based on the reducing.
  • 2. The method of claim 1, wherein the selecting further comprises selecting an adult patient with heart failure.
  • 3. The method of claim 1, wherein the selecting further comprises selecting an adult patient with congestive heart failure.
  • 4. The method of claim 1, wherein the medical device is implanted in the main pulmonary artery.
  • 5. The method of claim 1, wherein the medical device is implanted in a pulmonary artery branch.
  • 6. The method of claim 1, further comprising adjusting the effective diameter after the implanting, by further reducing the effective diameter.
  • 7. The method of claim 6, wherein the reduction of the effective diameter is performed gradually over hours, days or weeks after the implanting.
  • 8. The method of claim 6, wherein the adjusting includes expanding the effective diameter provided by the medical device, in the case where the medical device has been constricted too tightly, and needs to be expanded.
  • 9. The method of claim 1, further comprising imaging the portion of the pulmonary artery and measuring the effective diameter.
  • 10. The method of claim 1, further comprising monitoring one or more of the right ventricle (RV) systolic pressure, the left ventricle (LV) systolic pressure, the RV diastolic pressure, and the LV diastolic pressure and adjusting the effective diameter based on the monitoring.
  • 11. The method of claim 1, comprising detecting a pressure gradient across the portion of the pulmonary artery with the reduced effective diameter and adjusting the effective diameter based on the detecting.
  • 12. The method of claim 1, wherein adjusting the inner diameter of the medical device is performed before the implanting or after the implanting.
  • 13. The method of claim 1, wherein the medical device includes an inner tubular wall deployed within an outer tubular wall and wherein reducing the effective diameter is based on constricting a diameter of the inner tubular wall.
  • 14. The method of claim 13, forming a radial neck section in the inner tubular wall based on the constricting.
  • 15. The method of claim 1, wherein the medical device includes a constricting element configured to constrict an inner diameter of the medical device, the constricting element comprising: a loop section,a tail section configured to be pulled and/or pushed to adjust the circumference of the loop section; anda locking mechanism configured to lock the circumference of the loop section at the adjusted circumference.
  • 16. The method of claim 15 further comprising detaching the tail section after adjustment of the loop section circumference.
  • 17. The method of claim 1, comprising delivering the medical device to the pulmonary artery with a catheter.
  • 18. The method of claim 1, further comprising affecting a position of the interventricular septum during systole with the medical device based on the reducing.
  • 19. The method of claim 1, wherein reducing the effective diameter is configured to increase left ventricle ejection fraction.
  • 20. The method of claim 1, wherein the decrease in left ventricle end diastolic pressure is configured to reduce symptoms associated with one or more of systolic heart failure, diastolic heart failure, left ventricle (LV) heart failure and right ventricle (RV) heart failure.
  • 21. The method of claim 1, comprising adjusting the effective diameter after the implanting, by accessing a subcutaneous space and operating a part of the medical device that extends out of the blood vessel into said subcutaneous space.
  • 22. The method of claim 1, wherein said selecting an adult patient comprises selecting an adult patient with an additional therapeutic goal of increasing the left ventricle ejection fraction.
  • 23. The method of claim 1, comprising adjusting the effective diameter after the implanting, by further reducing the effective diameter, in steps.
  • 24. The method of claim 1, comprising adjusting the effective diameter pre-insertion, according to the patient's clinical condition.
  • 25. The method of claim 8, wherein the expanding further comprises retightening of the medical device.
RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/716,667 filed on Sep. 27, 2017, which claims the benefit of U.S. Provisional Patent Application No. 62/400,695 filed on Sep. 28, 2016. The contents of the above applications are all incorporated by reference as if fully set forth herein in their entirety.

US Referenced Citations (198)
Number Name Date Kind
3730186 Edmunds, Jr. et al. May 1973 A
4183102 Guiset Jan 1980 A
4425908 Simon Jan 1984 A
4601718 Possis et al. Jul 1986 A
4950276 Vince Aug 1990 A
5156620 Pigott Oct 1992 A
5167628 Boyles Dec 1992 A
5330528 Lazim Jul 1994 A
5332403 Kolff Jul 1994 A
5383892 Cardon et al. Jan 1995 A
5423851 Samuels Jun 1995 A
5554180 Turk Sep 1996 A
5554185 Block et al. Sep 1996 A
5618301 Hauenstein et al. Apr 1997 A
5662711 Douglas Sep 1997 A
5683411 Kavteladze et al. Nov 1997 A
5755779 Horiguchi May 1998 A
6120534 Ruiz Sep 2000 A
6312462 McDermott et al. Nov 2001 B1
6471635 Forsell Oct 2002 B1
6533800 Barbut Mar 2003 B1
6562066 Martin May 2003 B1
6595980 Barbut Jul 2003 B1
6616624 Kieval Sep 2003 B1
6638257 Amplatz Oct 2003 B2
6790230 Beyersdorf et al. Sep 2004 B2
6936057 Nobles Aug 2005 B1
6953476 Shalev Oct 2005 B1
7001409 Amplatz Feb 2006 B2
7128750 Stergiopulos Oct 2006 B1
7158832 Kieval et al. Jan 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7331993 White Feb 2008 B2
7442204 Schwammenthal et al. Oct 2008 B2
7497873 Bruckheimer Mar 2009 B1
7670367 Chouinard et al. Mar 2010 B1
7862502 Pool et al. Jan 2011 B2
7935144 Robin et al. May 2011 B2
7983765 Doan et al. Jul 2011 B1
7998220 Murphy Aug 2011 B2
8070708 Rottenberg et al. Dec 2011 B2
8091556 Keren et al. Jan 2012 B2
8556954 Ben MuVhar et al. Oct 2013 B2
8597349 Alkhatib Dec 2013 B2
8663314 Wood et al. Mar 2014 B2
8696611 Nitzan et al. Apr 2014 B2
8764772 Tckulve Jul 2014 B2
8808356 Braido et al. Aug 2014 B2
8858612 Ben-Muvhar et al. Oct 2014 B2
8911489 Ben-Muvhar Dec 2014 B2
8940040 Shahriari Jan 2015 B2
9034034 Nitzan et al. May 2015 B2
9125567 Gross et al. Sep 2015 B2
9393384 Kapur et al. Jul 2016 B1
9474839 Oran et al. Oct 2016 B2
9532868 Braido Jan 2017 B2
9572661 Robin et al. Feb 2017 B2
9603708 Robin et al. Mar 2017 B2
9629715 Nitzan et al. Apr 2017 B2
9649480 Sugimoto et al. May 2017 B2
9668861 McGuckin, Jr. Jun 2017 B2
9681948 Levi et al. Jun 2017 B2
9681949 Braido et al. Jun 2017 B2
9687242 Hendriksen et al. Jun 2017 B2
9707382 Nitzan et al. Jul 2017 B2
9713696 Yacoby et al. Jul 2017 B2
9724499 Rottenberg et al. Aug 2017 B2
9744059 Ben-Muvhar Aug 2017 B2
9775636 Fazio et al. Oct 2017 B2
9849006 Kozyak et al. Dec 2017 B2
10010328 Cragg Jul 2018 B2
10022128 Bödewadt et al. Jul 2018 B2
10492933 Jenni Dec 2019 B2
10568634 Goldie et al. Feb 2020 B2
10667931 Bruckheimer et al. Jun 2020 B2
10835394 Nae et al. Nov 2020 B2
10912645 Rottenberg et al. Feb 2021 B2
11135054 Nitzan et al. Oct 2021 B2
11224503 Karavany et al. Jan 2022 B2
11253685 Fahey et al. Feb 2022 B2
11357610 Karavany et al. Jun 2022 B2
11364132 Bellomo et al. Jun 2022 B2
20010053330 Ozaki Dec 2001 A1
20020107536 Hussein Aug 2002 A1
20030032976 Boucek Feb 2003 A1
20030097172 Shalev et al. May 2003 A1
20030144575 Forsell Jul 2003 A1
20030149473 Chouinard et al. Aug 2003 A1
20030167068 Amplatz Sep 2003 A1
20030236568 Hojeibane et al. Dec 2003 A1
20040077988 Tweden et al. Apr 2004 A1
20040111006 Alferness et al. Jun 2004 A1
20040236412 Brar et al. Nov 2004 A1
20050055082 Ben Muvhar Mar 2005 A1
20050096734 Majercak et al. May 2005 A1
20050148925 Rottenberg et al. Jul 2005 A1
20050165344 Dobak, III Jul 2005 A1
20050171556 Murphy Aug 2005 A1
20050182483 Osborne et al. Aug 2005 A1
20050234388 Amos et al. Oct 2005 A1
20050273160 Lashinski et al. Dec 2005 A1
20060025855 Lashinski et al. Feb 2006 A1
20060030920 Ben-Muvhar Feb 2006 A1
20060106449 Ben Muvhar May 2006 A1
20060106450 Ben Muvhar May 2006 A1
20060122692 Gilad et al. Jun 2006 A1
20060149360 Schwammenthal et al. Jul 2006 A1
20060178740 Stacchino et al. Aug 2006 A1
20060241745 Solem Oct 2006 A1
20070038259 Kieval et al. Feb 2007 A1
20070043435 Seguin et al. Feb 2007 A1
20070179590 Lu et al. Aug 2007 A1
20070198097 Zegdi Aug 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20080027268 Buckner Jan 2008 A1
20080097497 Assad et al. Apr 2008 A1
20080140110 Spence Jun 2008 A1
20080194905 Walsh Aug 2008 A1
20080208329 Bishop et al. Aug 2008 A1
20090099653 Suri et al. Apr 2009 A1
20090112312 LaRose et al. Apr 2009 A1
20090149950 Wampler Jun 2009 A1
20090198315 Boudjemline Aug 2009 A1
20090270974 Berez Oct 2009 A1
20100023046 Heidner et al. Jan 2010 A1
20100057192 Celermajer Mar 2010 A1
20100125288 Gelfand et al. May 2010 A1
20100185277 Braido et al. Jul 2010 A1
20100222633 Poirier Sep 2010 A1
20100249911 Alkhatib Sep 2010 A1
20100286758 Berglund Nov 2010 A1
20110021864 Criscione et al. Jan 2011 A1
20110046710 Mangiardi et al. Feb 2011 A1
20110054589 Bashiri et al. Mar 2011 A1
20110071624 Finch et al. Mar 2011 A1
20110098800 Braido et al. Apr 2011 A1
20110098802 Braido et al. Apr 2011 A1
20110213408 Gross et al. Sep 2011 A1
20110306916 Nitzan et al. Dec 2011 A1
20120101572 Kovalsky et al. Apr 2012 A1
20120123195 Woodruff et al. May 2012 A1
20120123556 Durgin May 2012 A1
20120149978 Olivera et al. Jun 2012 A1
20120165928 Nitzan et al. Jun 2012 A1
20120310323 Roeder Dec 2012 A1
20130073026 Russo et al. Mar 2013 A1
20130096580 Cohn et al. Apr 2013 A1
20130103162 Costello Apr 2013 A1
20130172981 Gross et al. Jul 2013 A1
20130178750 Sheehan et al. Jul 2013 A1
20130261531 Gallagher et al. Oct 2013 A1
20130274648 Weinberger Oct 2013 A1
20140012181 Sugimoto Jan 2014 A1
20140039537 Carrison Feb 2014 A1
20140128957 Losordo et al. May 2014 A1
20140155997 Braido Jun 2014 A1
20140277425 Dakin Sep 2014 A1
20140303710 Zhang et al. Oct 2014 A1
20140324094 Weber Oct 2014 A1
20140350565 Yacoby et al. Nov 2014 A1
20140350668 Delaloye et al. Nov 2014 A1
20140364686 McClurg Dec 2014 A1
20150073544 Gorman, III et al. Mar 2015 A1
20150148896 Karapetian et al. May 2015 A1
20150174308 Oran et al. Jun 2015 A1
20160151153 Sandstrom et al. Jun 2016 A1
20160296317 Timmermans et al. Oct 2016 A1
20170042551 Celermajer et al. Feb 2017 A1
20170065402 Tozzi et al. Mar 2017 A1
20170113026 Finch Apr 2017 A1
20170172771 Bruckheimer et al. Jun 2017 A1
20170215885 Goldie et al. Aug 2017 A1
20170216025 Nitzan et al. Aug 2017 A1
20170325946 Bell et al. Nov 2017 A1
20170340441 Rowe Nov 2017 A1
20170340460 Rosen et al. Nov 2017 A1
20170367855 Jenni Dec 2017 A1
20180021156 Ben-Muvhar et al. Jan 2018 A1
20180036109 Karavany et al. Feb 2018 A1
20180085128 Bellomo et al. Mar 2018 A1
20180092732 Kringle et al. Apr 2018 A1
20190000483 Mogensen Jan 2019 A1
20190307459 Celermajer et al. Oct 2019 A1
20200000582 Lashinski et al. Jan 2020 A1
20200205962 Karavany et al. Jul 2020 A1
20200229956 Jackson et al. Jul 2020 A1
20200289299 Bruckheimer et al. Sep 2020 A1
20200297516 Bellomo et al. Sep 2020 A1
20200352696 Radhakrishnan et al. Nov 2020 A1
20210161643 Totten et al. Jun 2021 A1
20210169634 Karavany et al. Jun 2021 A1
20210290358 Goodman et al. Sep 2021 A1
20210338465 Bruckheimer et al. Nov 2021 A1
20220015889 Lima et al. Jan 2022 A1
20220022881 Celermajer et al. Jan 2022 A1
20220039938 Karavany et al. Feb 2022 A1
20220117765 Yacoby et al. Apr 2022 A1
20220241063 Karavany et al. Aug 2022 A1
Foreign Referenced Citations (34)
Number Date Country
2 970 237 Jun 2016 CA
1430490 Jul 2003 CN
1672644 Sep 2005 CN
101687088 Mar 2010 CN
102764170 Nov 2012 CN
102961200 Mar 2013 CN
103202735 Jul 2013 CN
103930042 Jul 2014 CN
204106100 Jan 2015 CN
105392431 Mar 2016 CN
10102045 Jan 2003 DE
1576929 Sep 2005 EP
1849440 Oct 2007 EP
1870057 Dec 2007 EP
2567663 Mar 2013 EP
3300672 Apr 2018 EP
WO 2001035861 May 2001 WO
WO 03028522 Apr 2003 WO
WO2003028522 Apr 2003 WO
WO 2005084730 Sep 2005 WO
WO 2006131930 Dec 2006 WO
WO2007129220 Nov 2007 WO
WO2007144782 Dec 2007 WO
WO 2011156176 Dec 2011 WO
WO 2013096548 Jun 2013 WO
WO 2016013006 Jan 2016 WO
WO2016096529 Jun 2016 WO
WO 2016096529 Jun 2016 WO
WO 2017024357 Feb 2017 WO
WO 2017194437 Nov 2017 WO
WO 2018225059 Dec 2018 WO
WO 2020023512 Jan 2020 WO
WO 2020109979 Jun 2020 WO
WO 2023281507 Jan 2023 WO
Non-Patent Literature Citations (59)
Entry
Communication Pursuant to Article 94(3) EPC dated Jan. 3, 2020 From the European Patent Office Re. Application No. 17193799.8. (4 Pages).
European Search Report and the European Search Opinion dated Jan. 19, 2018 From the European Patent Office Re. Application No. 17193799.8. (9 Pages).
Final Official Action dated Jul. 2, 2020 from the US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (16 pages).
Official Action dated Dec. 3, 2019 From the US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (18 pages).
Ahmadi et al. “Percutaneously Adjustable Pulmonary Artery Band”, The Annals of the Thoracic Surgery, 60(6/Suppl.): S520-S522, Dec. 1995.
Amahzoune et al. “A New Endovascular Size Reducer for Large Pulmonary Outflow Tract”, European Journal of Cardio-Thoracic Surgery, 37(3): 730-752, Available Online Oct. 2, 2009.
Basquin et al. “Transcatheter Valve Insertion in a Model of Enlarged Right Ventricular Outflow Tracts”, The Journal of Thoracic and Cardiovascular Surgery, 139(1): 198-208, Jan. 2010.
Boudjemline et al. “Percutaneous Pulmonary Valve Replacement in a Large Right Ventricular Outflow Tract. An Experimental Study”, Journal of the American College of Cardiology, 43(6): 1082-1087, Mar. 17, 2004.
Boudjemline et al. “Steps Toward the Peercutaneous Replacement of Atrioventricular Valves. An Experimental Study”, Journal of the American College of Cardiology, 46(2): 360-365, Jul. 19, 2005.
Corno et al. “The Non-Circular Shape of FloWatch®-PAB Prvents the Need for Pulmonary Artery Reconstruction After Banding. Computational Fluid Dynamics and Clinical Correlations”, European Journal of Cardio-Thoracic Surgery, 29(1): 93-99, Available Online Dec. 6, 2005.
DiBardino et al. “A Method of Transcutaneously Adjustable Pulmonary Artery Banding for Staged Left Ventricular Retraining”, The Journal of Thoracic and Cardiovascular Surgery, 144(3): 553-556, Published Online Feb. 9, 2012.
Horita et al. “Development of a Reexpandable Covered Stent for Children”, Catheterization and Cardiovascular Interventions, 68(5): 727-734, Published Online Oct. 12, 2006.
Le Bret et al. “A New Percutaneously Adjustable, Thoracoscopically Implantable, Pulmonary Artery Banding: An Experimental Study”, The Annals of Thoracic Surgery, 72(4): 1358-1361, Oct. 31, 2001.
Mollet et al. “Development of a Device for Transcatheter Pulmonary Artery Banding: Evaluation in Animals”, European Heart Journal, 27(24): 3065-3072, Published Ahead of Print Oct. 31, 2006.
Mollet et al. “Off-Pump Replacement of the Pulmonary Valve in Large Right Ventricular Outflow Tracts: A Transcatheter Approach Using An Intravascular Infundibulum Reducer”, Pediatric Research, 62(4): 428-433, Oct. 2007.
Nakahata et al. “Percutaneous Bilateral Pulmonary Artery Banding Using a Re-Expandable Covered Stent: Preliminary Animal Study”, The Kisato Medical Journal, 41(2): 165-169, Sep. 2011.
Schranz et al. “Pulmonary Artery Banding in Infants and Young Children With Left Ventricular Dilated Cardiomyopathy: A Novel Therapeutic Strategy Before Heart Transplantation”, The Journal of Heart and Lung Transplantation, 32(5): 475-481, Published Online Feb. 12, 2013.
Talwar et al. “Changing Outcomes of Pulmonary Artery Banding With the Percutaneoulsy Adjustable Pulmonary Artery Band”, The Annals of Thoracic Surgery, 85(2): 593-598, Feb. 2008.
Watanabe et al. “How to Clamp the Main Pulmonary Artery During Video-Assisted Thorascopic Surgery Lobectomy”, European Journal of Cardio-Thoracic Surgery, 31(1): 129-131, Published Online Nov. 29, 2006.
Notice of Allowance dated Mar. 18, 2022 from US Patent and Trademark Office Re. U.S. Appl. No. 16/616,465. (22 pages).
Office Action dated Oct. 19, 2020 From the Israel Patent Office Re. Application No. 254791 and its Translation Into English. (6 Pages).
Final Official Action dated Dec. 21, 2021 from US Patent and Trademark Office Re. U.S. Appl. No. 16/616,465. (6 pages).
International Preliminary Report on Patentability dated Dec. 19, 2019 From the International Bureau of WIPO Re. Application No. PCT/IL2018/050604. (9 Pages).
International Preliminary Report on Patentability dated Jan. 24, 2017 From the International Bureau of WIPO Re. Application No. PCT/IL2015/050745. (8 Pages).
International Search Report and the Written Opinion dated Nov. 5, 2015 From the International Searching Authority Re. Application No. PCT/IL2015/050745. (14 Pages).
International Search Report and the Written Opinion dated Sep. 20, 2018 From the International Searching Authority Re. Application No. PCT/IL2018/050604. (12 Pages).
Notice of Allowance dated Jan. 24, 2020 From the US Patent and Trademark Office Re. U.S. Appl. No. 15/327,075. (8 pages).
Office Action dated Jun. 7, 2021 From the Israel Patent Office Re. Application No. 250181 and its Translation Into English. (7 Pages).
Office Action dated May 12, 2020 From the Israel Patent Office Re. Application No. 250181 and its Translation Into English. (7 Pages).
Official Action dated Feb. 2, 2018 From the US Patent and Trademark Office Re. U.S. Appl. No. 15/327,075. (15 pages).
Official Action dated Jun. 5, 2019 From the US Patent and Trademark Office Re. U.S. Appl. No. 15/327,075. (6 Pages).
Official Action dated Sep. 6, 2018 From the US Patent and Trademark Office Rc. U.S. Appl. No. 15/327,075. (9 pages).
Official Action dated Jul. 14, 2021 from the US Patent and Trademark Office Re. U.S. Appl. No. 16/616,465. (16 pages).
Official Action dated Dec. 20, 2018 From the US Patent and Trademark Office Re. U.S. Appl. No. 15/327,075. (12 pages).
Official Action dated Sep. 27, 2019 From the US Patent and Trademark Office Re. U.S. Appl. No. 15/327,075. (6 Pages).
Restriction Official Action dated Apr. 30, 2021 From the US Patent and Trademark Office Re. U.S. Appl. No. 16/616,465. (7 Pages).
Supplementary European Search Report and the European Search Opinion dated Feb. 4, 2021 From the European Patent Office Re. Application No. 18812772.4. (7 Pages).
Supplementary European Search Report and the European Search Opinion dated Feb. 9, 2018 From the European Patent Office Rc. Application No. 15825239.5. (7 Pages).
Bailey “Back to the Future! Bold New Indication for Pulmonary Artery Banding”, The Journal of Heart and Lung Transplantation, 32(5): 482-483, May 1, 2013.
Schranz et al. “Pulmonary Artery Banding in Infants and Young Children With Lleft Ventricular Dilated Cardiomyopathy: A Novel Therapeutic Strategy Before Heart Transplantation”, The Journal of Heart and Lung Transplantation, 32(5):475-481, May 31, 2013.
English Summary dated Mar. 17, 2022 of Notification of Office Action and Search Report dated Mar. 9, 2022 From the State Intellecutal Property Office of the People's Republic of China Re. Application No. 201880036104.4. (2 Pages).
Notification of Office Action and Search Report dated Mar. 9, 2022 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201880036104.4. (8 Pages).
Notification of Office Action and dated Jul. 5, 2022 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201710896715.3 and its Summary in English. (5 Pages).
Advisory Action dated Jun. 29, 2022 from US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (8 pages).
Official Action dated Aug. 13, 2021 from the US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (19 pages).
Notification of Office Action and Search Report dated Nov. 30, 2021 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201710896715.3 and its Summary in English.
Official Action dated Aug. 16, 2022 from US Patent and Trademark Office Re. U.S. Appl. No. 16/888,872. (43 pages).
Interview Summary dated Apr. 13, 2022 from US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (2 pages).
Office Action dated Jul. 13, 2022 From the Israel Patent Office Re. Application No. 250181. (5 Pages).
Translation Dated Jul. 20, 2022 of Office Action dated Jul. 13, 2022 From the Israel Patent Office Re. Application No. 250181. (4 Pages).
Final Official Action dated Feb. 22, 2022 from US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (23 pages).
Santamore et al. “Ventricular Interdependence: Significant Left Ventricular Contributions to Right Ventricular Systolic Function”, Progress in Cardiovascular Diseases, 40(4): 289-308, Jan./Feb. 1998.
Official Action dated Oct. 14, 2022 from the US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (24 pages).
Notice of Allowance dated Jun. 6, 2023 Together With Inteview Summary dated May 22, 2023 from the US Patent and Trademark Office Re. U.S. Appl. No. 15/716,667. (22 pages).
Office Action dated Jun. 20, 2023 From the Israel Patent Office Re. Application No. 271184. (4 Pages).
Office Action dated Oct. 30, 2022 From the Israel Patent Office Re. Application No. 271184. (4 Pages).
International Search Report and the Written Opinion dated Oct. 12, 2022 From the International Searching Authority Re. Application No. PCT/IL2022/050724. (15 Pages).
Communication Pursuant to Article 94(3) EPC dated May 24, 2023 From the European Patent Office Re. Application No. 17193799.8. (4 Pages).
Notice of Allowance dated Mar. 22, 2023 from the US Patent and Trademark Office Re. U.S. Appl. No. 16/888,872. (16 pages).
Related Publications (1)
Number Date Country
20200360024 A1 Nov 2020 US
Provisional Applications (1)
Number Date Country
62400695 Sep 2016 US
Continuations (1)
Number Date Country
Parent 15716667 Sep 2017 US
Child 16984166 US